IRTC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IRTC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, iRhythm Technologies's share price is $110.25. iRhythm Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $18.97. Hence, iRhythm Technologies's PS Ratio for today is 5.81.
The historical rank and industry rank for iRhythm Technologies's PS Ratio or its related term are showing as below:
During the past 11 years, iRhythm Technologies's highest PS Ratio was 28.94. The lowest was 3.16. And the median was 10.23.
iRhythm Technologies's Revenue per Sharefor the three months ended in Dec. 2024 was $5.24. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $18.97.
During the past 12 months, the average Revenue per Share Growth Rate of iRhythm Technologies was 17.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 19.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 18.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 23.20% per year.
During the past 11 years, iRhythm Technologies's highest 3-Year average Revenue per Share Growth Rate was 43.80% per year. The lowest was -11.20% per year. And the median was 20.60% per year.
The historical data trend for iRhythm Technologies's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iRhythm Technologies Annual Data | |||||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||||
PS Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
24.83 | 10.69 | 6.82 | 6.63 | 4.75 |
iRhythm Technologies Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
PS Ratio | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
6.63 | 6.94 | 6.19 | 4.12 | 4.75 |
For the Medical Devices subindustry, iRhythm Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where iRhythm Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
iRhythm Technologies's PS Ratio for today is calculated as
PS Ratio | = | Share Price | / | Revenue per Share (TTM) |
= | 110.25 | / | 18.966 | |
= | 5.81 |
iRhythm Technologies's Share Price of today is $110.25.
iRhythm Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.97.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PS Ratio | = | Market Cap | / | Revenue |
The Revenue here is for the trailing 12 months.
iRhythm Technologies (NAS:IRTC) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.
Be Aware
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Thank you for viewing the detailed overview of iRhythm Technologies's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Patrick Michael Murphy | officer: CLO & EVP RA/QA MrktAcs & Gov | 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121 |
Quentin S. Blackford | director, officer: President and CEO | 7475 LUSK BLVD., SAN DIEGO CA 92121 |
Abhijit Y Talwalkar | director | ONE AMD PLACE, PO BOX 3453, SUNNYVALE CA 94088 |
Brice Bobzien | officer: Chief Financial Officer | C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103 |
Mervin Smith | officer: EVP Strategic Business Ops | C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103 |
Chad Patterson | officer: Chief Commercial Officer | 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121 |
Minang Turakhia | officer: EVP, CMO & CSO | C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH ST #600, SAN FRANCISCO CA 94103 |
Marc W. Rosenbaum | officer: Chief Accounting Officer | 7475 LUSK BLVD., SAN DIEGO CA 92121 |
Sumi Shrishrimal | officer: EVP, Chief Risk Officer | 6340 SEQUENCE DRIVE, SAN DIEGO CA 92121 |
Daniel G. Wilson | officer: EVP, Strategy Corp Dev Inv Rel | 699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103 |
Mark J. Day | officer: EVP, Research & Development | C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 500, SAN FRANCISCO CA 94103 |
Mojdeh Poul | director | 3M COMPANY OFFICE OF GENERAL COUNSEL, 3M CENTER, ST PAUL MN 55144-1000 |
Brian B Yoor | director | 100 ABBOTT PARK ROAD, AP6A-2, D-032L, ABBOTT PARK IL 60064 |
Douglas Devine | officer: Chief Financial Officer | C/O IRHYTHM TECHNOLOGIES, INC., 699 8TH STREET, SUITE 600, SAN FRANCISCO CA 94103 |
Bairey Merz Cathleen Noel | director | 16664 CUMBRE VERDE COURT, PACIFIC PALISADES CA 90272 |
From GuruFocus
By GuruFocus News • 11-13-2024
By GuruFocus News • 11-13-2024
By Marketwired • 10-30-2024
By GlobeNewswire • 10-30-2024
By GuruFocus News • 11-28-2024
By Marketwired • 12-30-2024
By GuruFocus News • 12-30-2024
By GuruFocus News • 02-13-2025
By GuruFocus News • 01-08-2025
By Marketwired • 10-30-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.